Pharmacological therapy

PreclinicalSmall molecule

Pharmacological therapy is one of 6 small molecule programs targeting Lumbar Disc Herniation. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lumbar Disc HerniationActive, not recruiting

Lumbar Disc HerniationPreclinical

Active, not recruiting

Competition

Competitive Landscape

10 competitors in Lumbar Disc Herniation

#DrugCompanyPhaseTrials

Condoliase

SSeikagaku Corporation

Phase 3

2 2

Kenalog

BBassett Healthcare

Preclinical

1 3

SI-6603

SSeikagaku Corporation

Phase 2

3 4

Platelet Rich Plasma

ZZagazig University

Preclinical

1 5

Pharmacological therapy

FFoundation University Islamabad

Preclinical

1 6

Conventional Medicine

JJaseng Medical Foundation

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Lumbar Disc Herniation1 trial

Strengthening Exercise and Activities of Daily Living Instructions for Patients With Lumbar Disc Herniation

Completed·—·N/A·NCT05021718·70 enrolled

Dyspnea1 trial

Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma

Recruiting·FFoundation University Islamabad·N/A·NCT06609941·32 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Pharmacological therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pharmacological therapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pharmacological therapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Foundation University Islamabad company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: FFoundation University Islamabad

Pharmacological therapy

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Lumbar Disc Herniation1 trial

Dyspnea1 trial

References

Drug Info

Quick Facts

Related News